基本信息
浏览量:8
职业迁徙
个人简介
Inspired by issues of healthcare inequity and global human rights, Henry Daniell has developed and advanced a novel approach to orally delivering affordable biopharmaceuticals, eliminating expensive injections and refrigeration. He has developed drugs to treat dental caries, diabetes, hemophilia, pulmonary hypertension, diabetic retinopathy, and Alzheimer’s disease, as well as oral vaccines for cholera, tuberculosis, malaria, polio, and plague. Daniell is a fellow of the American Association for the Advancement of Science and the 14th foreign member of Italy’s 240-year-old National Academy of Science. He has been honored for his groundbreaking work by organizations including the American Diabetes Association, the American Heart Association, and the Bill and Melinda Gates Foundation, and is the recipient of the Bayer Healthcare Global Award.
The high cost of current vaccines and biopharmaceuticals is largely due to their complex production and delivery methods, including the significant costs of fermentation and purification systems and additional expenses associated with cold storage, transportation and sterile delivery. Therefore, Dr. Daniell pioneered and advanced the concept of expressing foreign genes in chloroplasts with major emphasis on vaccines and biopharmaceuticals. In addition to high levels of expression, protection of therapeutic proteins in the stomach by bio-encapsulation within plant cells and their release in the gut for presentation to the mucosal immune system or circulatory system, facilitate oral delivery of vaccines or auto-antigens. Oral delivery of bio-encapsulated vaccine antigens in high doses along with prime boost confers both mucosal and systemic immunity and greater protection against pathogens than delivery by injections alone.
研究兴趣
论文共 313 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in immunology (2023)
Cellular immunology (2023): 104742-104742
Methods in molecular biology (Clifton, N.J.) (2023): 73-92
Plant biotechnology journalno. 1 (2023): 3-4
Nature biotechnologyno. 9 (2023): 1186-1187
加载更多
作者统计
#Papers: 313
#Citation: 21989
H-Index: 81
G-Index: 142
Sociability: 6
Diversity: 3
Activity: 50
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn